Abel Hall »

Esperion Therapeutics shares owned by Abel Hall

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Abel Hall from 13F filings

Historical chart of Abel Hall investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Abel Hall consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Abel Hall

Quarter filed Position value Share count Share price at filing
2025-09-30 $32k 12k 2.65
2025-06-30 $12k 12k 0.98

More positions owned by Abel Hall

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Intl Small Cap V (DISV)
Apple (AAPL)
Dimensional Etf Trust Intl High Profit (DIHP)
Amazon (AMZN)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Dimensional Etf Trust Global Core Plus (DFGP)
Exxon Mobil Corporation (XOM)

View all positions for Abel Hall

Top funds holding Esperion Therapeutics

BlackRock
Vanguard Group
Two Seas Capital
Daniel D. Thurber
PenderFund Capital Management
Geode Capital Management
State Street Corporation
Nuveen
AIGH Capital Management
Marshall Wace
Royce & Associates
Two Sigma Investments
Jane Street
Citadel Advisors
Two Sigma Advisers

View all funds holding Esperion Therapeutics